Read + Share
Amedeo Smart
Independent Medical Education
Liu S, Xie SM, Liu W, Gagea M, et al. Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment. Breast Cancer Res 2023;25:62.PMID: 37280713
Email
LinkedIn
Facebook
Twitter
Privacy Policy